Anne‐Pascale Meert
About
In The Last Decade
Anne‐Pascale Meert
114 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 105
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.2k
- Epidemiology 582
- Molecular Biology 529
- Radiology, Nuclear Medicine and Imaging 503
Countries citing papers authored by Anne‐Pascale Meert
This map shows the geographic impact of Anne‐Pascale Meert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Pascale Meert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Pascale Meert more than expected).
Fields of papers citing papers by Anne‐Pascale Meert
This network shows the impact of papers produced by Anne‐Pascale Meert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Pascale Meert. The network helps show where Anne‐Pascale Meert may publish in the future.
Co-authorship network of co-authors of Anne‐Pascale Meert
This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Pascale Meert. A scholar is included among the top collaborators of Anne‐Pascale Meert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Pascale Meert. Anne‐Pascale Meert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study | 2 |
| 4 | [A 38 years old female with inflammatory myofibroblastic tumor and lactic acidosis]. | 1 |
| 5 | Les recommandations de pratique clinique de l'European Lung Cancer Working Party: Mises à jour. | 1 |
| 6 | 19 | |
| 7 | First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicentre academic phase II study in caucasian patients (pts) (NCT00339586) | 1 |
| 8 | 72 | |
| 9 | 10 | |
| 10 | El valor de captacion estandarizado (SUVmax) del tumor primario medido con tomografia de emission de postrones con fluorodesoxiglucosa (FDG-PET) tiene valor pronostico para la supervivencia en el cancer de pulmon no microcitico (CPNMC): Una revision sistematica y metaanalisis (MA) del European Lung Cancer Working Party para el IASLC Lung Cancer Staging Project | 1 |
| 11 | Thérapie photodynamique en cancérologie cervico-faciale | 1 |
| 12 | 0 | |
| 13 | 8 | |
| 14 | Prognostic role of thyroid transcription factor (TTF-1) in lung cancer: a meta-analysis of the published studies | 0 |
| 15 | Does c-erbB-2 play a role in the first steps of lung carcinogenesis? | 2 |
| 16 | 39 | |
| 17 | VEGF et survie des patients atteints d'un cancer pulmonaire. Revue systématique avec méta-analyse. | 53 |
| 18 | Citation factors are not reflecting the methodological quality of lung cancer randomised trials. | 3 |
| 19 | Haematological colony-stimulating factor (CSF) in the treatment of small-cell lung cancer (SCLC): a systematic review of the literature with meta-analysis. | 0 |
| 20 | Phase II and III studies with new drugs for non small cell lung carcinoma: a systematic review of the literature with a methodology quality assessment | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.